136 related articles for article (PubMed ID: 16236621)
1. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion.
Bauwens D; Hantson P; Laterre PF; Michaux L; Latinne D; De Tourtchaninoff M; Cosnard G; Hernalsteen D
Leuk Lymphoma; 2005 Nov; 46(11):1671-4. PubMed ID: 16236621
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells.
Maral S; Albayrak M; Pala C; Yildiz A; Sahin O; Ozturk HB
Cell Tissue Bank; 2018 Dec; 19(4):831-832. PubMed ID: 30099684
[TBL] [Abstract][Full Text] [Related]
3. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
Marcacci G; Corazzelli G; Becchimanzi C; Arcamone M; Capobianco G; Russo F; Frigeri F; Pinto A
Bone Marrow Transplant; 2009 Jul; 44(2):133-5. PubMed ID: 19182835
[No Abstract] [Full Text] [Related]
4. Severe motor aphasia after reinfusion of cryopreserved autologous stem cells after myeloablative conditioning.
Hausmann A; Fischer N; Breitkopf S; Menne F; Jess K; Schmidmayr S; Wendtner CM; Hentrich M
Transfusion; 2016 Oct; 56(10):2615-2617. PubMed ID: 27465621
[TBL] [Abstract][Full Text] [Related]
5. Clinical side effects during peripheral blood progenitor cell infusion.
Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
[TBL] [Abstract][Full Text] [Related]
6. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells.
Higman MA; Port JD; Beauchamp NJ; Chen AR
Bone Marrow Transplant; 2000 Oct; 26(7):797-800. PubMed ID: 11042664
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion.
Júnior AM; Arrais CA; Saboya R; Velasques RD; Junqueira PL; Dulley FL
Bone Marrow Transplant; 2008 Jan; 41(1):95-6. PubMed ID: 17934528
[No Abstract] [Full Text] [Related]
8. Severe vasospastic angina with hemodynamic compromise related to the infusion of dimethyl sulfoxide (DMSO)-cryopreserved autologous peripheral blood stem cells.
Bambace NM; Lachance S
Ann Hematol; 2013 Nov; 92(11):1571-2. PubMed ID: 23580150
[No Abstract] [Full Text] [Related]
9. Neurotoxicity Associated With Dimethyl Sulfoxide Used in Allogeneic Stem Cell Transplantation.
Ataseven E; Tüfekçi Ö; Yilmaz Ş; Güleryüz H; Ören H
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e297-e299. PubMed ID: 28121745
[TBL] [Abstract][Full Text] [Related]
10. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Otrock ZK; Beydoun A; Barada WM; Masroujeh R; Hourani R; Bazarbachi A
Haematologica; 2008 Mar; 93(3):e36-7. PubMed ID: 18310533
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G
Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106
[TBL] [Abstract][Full Text] [Related]
12. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
13. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
14. Transient loss of consciousness in pediatric recipients of dimethylsulfoxide (DMSO)-cryopreserved peripheral blood stem cells independent of morphine co-medication.
Schlegel PG; Wölfl M; Schick J; Winkler B; Eyrich M
Haematologica; 2009 Oct; 94(10):1473-5. PubMed ID: 19608681
[No Abstract] [Full Text] [Related]
15. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components.
Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W
Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908
[TBL] [Abstract][Full Text] [Related]
16. [Relevant low toxicities with rhG-CSF mobilized and cryopreserved autologous peripheral blood stem cell return infusions in children].
Wang JW; Tang SQ; Lü SG; Ran CR; Yang G; Liu Y; Gao XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):404-7. PubMed ID: 17493357
[TBL] [Abstract][Full Text] [Related]
17. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion.
Dhodapkar M; Goldberg SL; Tefferi A; Gertz MA
Am J Hematol; 1994 Feb; 45(2):187-8. PubMed ID: 7908165
[TBL] [Abstract][Full Text] [Related]
18. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
19. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
Hoyt R; Szer J; Grigg A
Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
